Corvese Brian 4

What Happened

• Brian Corvese, a director of Agenus Inc. (AGEN), received an award of 210,000 derivative shares (an option grant) on April 24, 2026. The reported acquisition price is $0.00 (no cash paid) and the filing treats this as an award/derivative grant rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-24; SEC filing date: 2026-04-28.
• Transaction type: A (Award/Grant of derivative securities); amount: 210,000 shares; price reported: $0.00.
• Shares owned after transaction: not specified in the summary information provided in this prompt/filling.
• Footnote: The option was awarded under the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan and vests on the one-year anniversary of the grant date.
• Filing timeliness: filed April 28 for an April 24 grant (filing date shown on the Form 4).

Context

• This was an equity award (derivative/option), not an exercise or sale — there were no proceeds or share sales associated with the grant at filing. The award vests in one year, meaning the shares/options are not immediately transferable or exercisable until vesting conditions are met. Such grants are commonly used for compensation/retention; they do not by themselves indicate immediate buying or selling by the insider.